Cost implications of IV versus oral anti-angiogenesis therapies in patients with advanced renal cell carcinoma: retrospective claims database analysis

Current Medical Research and Opinion, 2009 Aug;25(8):2081-90

View abstract

Authors

Duh M, Dial E, Antras L, Choueiri T, Fournier A, Rodermund D, Neary M, Oh W